NDUFA6

NADH dehydrogenase [ubiquinone] 1 alpha subco · P56556 · NDUFA6 on Sugi Atlas →

1,888 patent compounds predicted against NDUFA6, 1,111 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Auraptene Auraptene (SCHEMBL2535029) 1.00 5/20
Auraptene Auraptene (SCHEMBL2535034) 1.00 5/20
SCHEMBL11456503 SCHEMBL11456503 0.71 4/20
SCHEMBL11456504 SCHEMBL11456504 0.71 4/20
SCHEMBL11457189 SCHEMBL11457189 0.69 4/20
SCHEMBL11457190 SCHEMBL11457190 0.69 4/20
SCHEMBL8491443 SCHEMBL8491443 0.56 4/20
SCHEMBL8489900 SCHEMBL8489900 0.52 4/20
SCHEMBL8489907 SCHEMBL8489907 0.52 4/20
SCHEMBL8492838 SCHEMBL8492838 0.52 4/20
SCHEMBL8492845 SCHEMBL8492845 0.52 4/20
SCHEMBL8489902 SCHEMBL8489902 0.51 4/20
SCHEMBL8489908 SCHEMBL8489908 0.51 4/20
SCHEMBL8491154 SCHEMBL8491154 0.51 4/20
SCHEMBL8491160 SCHEMBL8491160 0.51 4/20
SCHEMBL8491619 SCHEMBL8491619 0.50 4/20
SCHEMBL8491624 SCHEMBL8491624 0.50 4/20
SCHEMBL8491634 SCHEMBL8491634 0.50 4/20
SCHEMBL8494171 SCHEMBL8494171 0.50 4/20
SCHEMBL8494175 SCHEMBL8494175 0.50 4/20

Clinical trials — most relevant to NDUFA6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease PHASE3COMPLETED
Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease PHASE3COMPLETED
Effect of Montelukast Versus Co Enzyme in Sepsis PHASE2/PHASE3COMPLETED
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder PHASE2WITHDRAWN
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus) PHASE1/PHASE2NOT_YET_RECRUITING
Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy PHASE2ACTIVE_NOT_RECRUITING
Parkinson's Disease Treatment With Coenzyme Q10 PHASE2COMPLETED
Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)? PHASE1UNKNOWN
Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine nanCOMPLETED
The Natural History of Mitochondrial Diseases nanRECRUITING
Nicotinamide Riboside and Mitochondrial Biogenesis nanCOMPLETED
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) nanRECRUITING
Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection nanCOMPLETED
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases nanRECRUITING
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Natural History in Primary Mitochondrial Myopathies nanRECRUITING
Assessment of Follicular Fluid Level of Coenzyme Q10 in Women Undergoing ICSI nanUNKNOWN
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders nanCOMPLETED
Nicotinamide Riboside in Ulcerative Colitis nanRECRUITING
Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome. nanUNKNOWN
Diagnostic Odyssey Survey 2 nanCOMPLETED
Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability. nanUNKNOWN
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING
Pharmacokinetic Study on Three Formulations of Coenzyme Q10 With Different Carriers nanUNKNOWN
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a NDUFA6 binder may also engage these)

ProteinNameSimilarity
Q0MQA4 1.000 Q0MQA4 →
Q0MQA3 1.000 Q0MQA3 →
Q0MQA5 1.000 Q0MQA5 →
Q02366 1.000 Q02366 →
Q9CQZ5 0.998 Q9CQZ5 →
Q9LHI0 0.984 Q9LHI0 →
P42114 0.979 P42114 →
Q4WHK3 0.976 Q4WHK3 →
Q4IN52 0.976 Q4IN52 →
Q8K215 0.973 Q8K215 →
A1C9A5 0.972 A1C9A5 →
Q9NRP4 0.972 Q9NRP4 →
B5XD90 0.971 B5XD90 →
P82116 0.971 P82116 →
B6GWX1 0.970 B6GWX1 →
Q5AX36 0.970 Q5AX36 →
Q5BBH7 0.970 Q5BBH7 →
A0JPA6 0.970 A0JPA6 →
Q6DCS1 0.970 Q6DCS1 →
B8JLQ0 0.968 B8JLQ0 →
Q9DA03 0.968 Q9DA03 →
Q0VCG0 0.968 Q0VCG0 →
Q0CVW0 0.968 Q0CVW0 →
Q4QQY2 0.968 Q4QQY2 →
Q9HD34 0.968 Q9HD34 →
A4DA73 0.968 A4DA73 →
A2R2Q4 0.968 A2R2Q4 →
A5PLG0 0.968 A5PLG0 →
Q6TUF2 0.967 Q6TUF2 →
Q4SQJ2 0.967 Q4SQJ2 →